Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — FY2022/23 Earnings Presentation
12 slides from Coloplast A/s Class B's earnings presentation, 2023
Slide 1: Making life easier
Conference call presentation FY 2022/23 Jurgen Ostomy Care user Making life easier Strive25: Sustainable Growth Leadership Ostomy Care | Continence Care | Advanced Wound Care | Interventional Urology | Voice and Respiratory Care
Slide 2: Forward-looking statements
Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking statements
Slide 3: FY 2022/23 financial result in line with guidance
NEW IMAGE FY 2022/23 financial result in line with guidance Update picture Organic Reported ROIC growth EBIT margin 8% 28% * * 17% ** *before special items **after tax and before special items 3 Morten | Denmark
Slide 4: Strategic highlights from Strive25 – Sustainable growth leadership
Strategic highlights from Strive25 – Sustainable growth leadership Growth Innovation US Ostomy Care Luja™, a new male intermittent catheter with a Micro-hole Zone Technology • Advanced our competitive position, market share increased to 15-20% from ~15% • Launched in six markets with positive feedba
Slide 5: FY 2022/23 organic growth of 8% was broad-based and driven by a solid year in Chronic Care
FY 2022/23 organic growth of 8% was broad-based and driven by a solid year in Chronic Care, despite low single-digit growth in China FY 2022/23 revenue by business area FY 2022/23 revenue by geography Business Reported revenue Organic growth Share of organic Geographic Reported revenue Organic growt
Slide 6: 2022/23 reported revenue grew 9%, with ~3%-points from acquisitions
2022/23 reported revenue grew 9%, with ~3%-points from acquisitions, mostly Atos Medical, and ~2%-points negative impact from currencies FY 2022/23 Revenue development (mDKK) FY 2022/23 highlights • Reported revenue increased by DKK 1,921 million or 9% vs. last year • Organic growth was 8% or DKK 1,
Slide 7: FY 2022/23 reported EBIT margin of 28%, reflecting inflationary headwind on input costs
FY 2022/23 reported EBIT margin of 28%1, reflecting inflationary headwind on input costs and an increase in operating expenses FY 2022/23 EBIT margin development before special items (%) FY 2022/23 highlights • Gross margin was 67%, against 69% last year • Negative impact from: raw material price in
Slide 8: Adj. FCF in FY was DKK 3,749 million
Adj. FCF in FY was DKK 3,749 million. Operating cash flow impacted by higher income tax paid, interest payments, and higher working capital FCF development1 FY 2022/23 highlights • Free cash flow for FY 2022/23 was an outflow of DKK 4,731 million compared to an outflow of DKK 6,660 million last year
Slide 9: FY 2023/24 guidance: organic growth of around 8% and EBIT margin of 27-28%
FY 2023/24 guidance: organic growth of around 8% and EBIT margin* of 27-28% Organic revenue growth Around 8% Reported revenue growth in DKK Around 12% Reported EBIT margin* 27-28% Effective tax rate Around 22% Capital expenditures Around 1.4 bn DKK *before special items 9
Slide 10: FY 2023/24: continued good growth momentum; easing of inflationary headwinds
FY 2023/24: continued good growth momentum; easing of inflationary headwinds and 1%-p EBIT margin dilution from Kerecis Revenue growth assumptions Key impacts on gross- and EBIT margin development in 2023/24 ILLUSTRATIVE FY 2023/24 organic growth expected at ~68% around 8% in constant currencies ~67
Slide 11: Our Strive25 strategy supports continued long-term value creation
Our Strive25 strategy supports continued long- term value creation through revenue and earnings growth Long-term financial guidance 8-10% more than 30% organic growth EBIT margin p.a.1 beyond 2024/252 1 Raised to 8-10%, from previously 7-9%, on July 7 as a result of the acquisition of Kerecis, expec
Slide 12: Making life easier for people with intimate healthcare needs
Mission Making life easier for people with intimate healthcare needs Values Closeness… to better understand Passion… to make a difference Respect and responsibility… to guide us Vision Setting the global standard for listening and responding